Postoperative Periclavicular Radiotherapy in Breast Cancer Patients with 1-3 Positive Axillary Lymph Nodes. Outcome and Morbidity

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2012 Mar 14

PMID 22410836

Citations 5

Authors

A Biancosino

M Bremer

J H Karstens

C Biancosino

A Meyer

Affiliations

Soon will be listed here.

Abstract

Purpose: The goal of this work was to examine the possible influence of periclavicular irradiation on outcome of breast cancer patients with 1-3 positive lymph nodes with special emphasis on late toxicity rates.

Patients And Methods: Between 1997 and 2000, 235 breast cancer patients (T1-2, 1-3 involved lymph nodes) were treated at our department following breast conservative surgery: 139 patients (59.1%) had one, 62 patients (26.4%) two, and 34 patients (14.5%) three positive lymph nodes. Extracapsular spread (ECS) was described in 72 patients (30.6%). There were 67 patients (28.5%) who received additional radiotherapy to the ipsilateral periclavicular lymph nodes (PCLNI), while 168 patients did not (noPCLNI). Patients were re-examined or contacted by phone with regard to treatment-related late effects.

Results: After a median follow-up of 78 months (range 7-107 months), 22 patients (9.4%) developed local, 9 (3.8%) axillary, 4 periclavicular (1.7%), and 41 distant failure (17.4%). The actuarial 8-year locoregional recurrence-free (LRRFS), disease-free (DFS), and overall survival rates (OS) were 83%, 67%, and 74%, respectively. Survival data for the PCLNI vs. noPCLNI group were 72% vs. 89% (p = 0.3), 56% vs. 73% (p = 0.4), and 86% vs. 70% (p = 0.3), respectively. No higher toxicity rates were reported in the PCLNI group compared to the noPCLNI group.

Conclusion: We could not demonstrate any difference in outcome in breast cancer patients with 1-3 positive axillary lymph node metastases with or without periclavicular lymph node irradiation. In addition, patients with PCLNI did not complain about higher rates of late toxicities. However, patients with ECS, which may predict for locoregional failure, may benefit from adjuvant periclavicular irradiation.

Citing Articles

Regional nodal irradiation in pT1-2N1 breast cancer patients treated with breast-conserving surgery and whole breast irradiation.

Park S, Kim J Radiat Oncol J. 2020; 38(1):44-51.

PMID: 32229808 PMC: 7113153. DOI: 10.3857/roj.2019.00647.

Outcomes in Patients with pT1-T2, pN0-N1 Breast Cancer After Conservative Surgery and Whole-breast Radiotherapy.

Trignani M, Di Carlo C, Cefalogli C, Nuzzo M, Ursini L, Caravatta L In Vivo. 2017; 31(1):151-158.

PMID: 28064235 PMC: 5354142. DOI: 10.21873/invivo.11039.

Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy.

Wen G, Zhang J, Zhang Y, Zhu Y, Huang X, Guan X J Breast Cancer. 2016; 19(2):176-84.

PMID: 27382394 PMC: 4929259. DOI: 10.4048/jbc.2016.19.2.176.

Influence of surgical margins on the outcome of breast cancer patients: a retrospective analysis.

Bernardi S, Bertozzi S, Londero A, Gentile G, Angione V, Petri R World J Surg. 2014; 38(9):2279-87.

PMID: 24819382 DOI: 10.1007/s00268-014-2596-x.

The effects of ECE on the benefits of PMRT for breast cancer patients with positive axillary nodes.

Geng W, Zhang B, Li D, Liang X, Cao X J Radiat Res. 2013; 54(4):712-8.

PMID: 23392824 PMC: 3709674. DOI: 10.1093/jrr/rrt003.

References

Reddy S, Kiel K . Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation. Breast J. 2007; 13(1):12-8. DOI: 10.1111/j.1524-4741.2006.00357.x. View

Yoshida K, Yamazaki H, Takenaka T, Tanaka E, Kotsuma T, Fujita Y . Objective assessment of dermatitis following post-operative radiotherapy in patients with breast cancer treated with breast-conserving treatment. Strahlenther Onkol. 2010; 186(11):621-9. DOI: 10.1007/s00066-010-2134-1. View

Sharma R, Hamilton A, Beith J . LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Cochrane Database Syst Rev. 2008; (4):CD004562. DOI: 10.1002/14651858.CD004562.pub3. View

. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000; 355(9217):1757-70. View

Classen J, Nitzsche S, Wallwiener D, Kristen P, Souchon R, Bamberg M . Fibrotic changes after postmastectomy radiotherapy and reconstructive surgery in breast cancer. A retrospective analysis in 109 patients. Strahlenther Onkol. 2010; 186(11):630-6. DOI: 10.1007/s00066-010-2158-6. View

Nestle-Kramling C, Bolke E, Budach W, Peiper M, Niederacher D, Janni W . [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review]. Strahlenther Onkol. 2011; 187(10):656-64. DOI: 10.1007/s00066-011-2251-5. View

Tai P, Joseph K, Sadikov E, Mahmood S, Lien F, Yu E . Nodal ratios in node-positive breast cancer--long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy. Int J Radiat Oncol Biol Phys. 2007; 68(3):662-6. DOI: 10.1016/j.ijrobp.2007.01.057. View

Truong P, Vinh-Hung V, Cserni G, Woodward W, Tai P, Vlastos G . The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer. 2008; 44(12):1670-7. DOI: 10.1016/j.ejca.2008.05.011. View

Johansson S, Svensson H, Denekamp J . Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys. 2000; 48(3):745-50. DOI: 10.1016/s0360-3016(00)00674-x. View

10.

Stranzl H, Mayer R, Ofner P, Peintinger F, Prettenhofer U, Hackl A . Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation. Strahlenther Onkol. 2004; 180(1):31-7. DOI: 10.1007/s00066-004-1170-0. View

11.

Woodward W, Vinh-Hung V, Ueno N, Cheng Y, Royce M, Tai P . Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006; 24(18):2910-6. DOI: 10.1200/JCO.2005.03.1526. View

12.

. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 1995; 31(5):1049-91. DOI: 10.1016/0360-3016(95)90159-0. View

13.

Van De Steene J, Vinh-Hung V, Cutuli B, Storme G . Adjuvant radiotherapy for breast cancer: effects of longer follow-up. Radiother Oncol. 2004; 72(1):35-43. DOI: 10.1016/j.radonc.2004.04.004. View

14.

Wapnir I, Anderson S, Mamounas E, Geyer Jr C, Jeong J, Tan-Chiu E . Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006; 24(13):2028-37. DOI: 10.1200/JCO.2005.04.3273. View

15.

Livi L, Paiar F, Simontacchi G, Barca R, Detti B, Fondelli S . Loco regional failure pattern after lumpectomy and breast irradiation in 4,185 patients with T1 and T2 breast cancer. Implications for nodal irradiation. Acta Oncol. 2006; 45(5):564-70. DOI: 10.1080/02841860600658211. View

16.

Gruber G, Berclaz G, Altermatt H, Greiner R . Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?. Strahlenther Onkol. 2003; 179(10):661-6. DOI: 10.1007/s00066-003-1084-2. View

17.

Chua B, Ung O, Boyages J . Competing considerations in regional nodal treatment for early breast cancer. Breast J. 2002; 8(1):15-22. DOI: 10.1046/j.1524-4741.2002.08004.x. View

18.

Johansson S, Svensson H, Denekamp J . Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2002; 52(5):1207-19. DOI: 10.1016/s0360-3016(01)02743-2. View

19.

Livi L, Scotti V, Saieva C, Meattini I, Detti B, Simontacchi G . Outcome after conservative surgery and breast irradiation in 5,717 patients with breast cancer: implications for supraclavicular nodal irradiation. Int J Radiat Oncol Biol Phys. 2009; 76(4):978-83. DOI: 10.1016/j.ijrobp.2009.03.001. View

20.

DONEGAN W, Stine S, SAMTER T . Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer. 1993; 72(3):778-82. DOI: 10.1002/1097-0142(19930801)72:3<778::aid-cncr2820720324>3.0.co;2-j. View